microorgan
particularli
bacteria
frequent
found
lower
airway
copd
patient
stabl
state
exacerb
hostepathogen
relationship
copd
complex
dynam
process
characteris
frequent
chang
pathogen
strain
load
subsequ
host
immun
respons
exacerb
detriment
event
cours
copd
evid
suggest
may
caus
microorgan
consid
bacteri
exacerb
recent
find
base
molecular
type
demonstr
acquisit
new
strain
bacteria
antigen
chang
preexist
strain
import
trigger
exacerb
onset
even
clinic
stabl
copd
patient
presenc
microorgan
lower
airway
may
caus
harm
effect
induc
chronic
lowgrad
airway
inflamm
lead
increas
exacerb
frequenc
acceler
declin
lung
function
impair
healthrel
qualiti
life
besid
intralumin
localis
distal
airway
bacteria
found
bronchial
wall
parenchym
lung
tissu
copd
patient
therefor
isol
pathogen
bacteria
stabl
copd
consid
form
chronic
infect
rather
colonis
new
approach
may
import
implic
manag
patient
copd
bacteria
chronic
obstruct
pulmonari
diseas
phenotyp
colonis
exacerb
infect
microorgan
summari
microorgan
particularli
bacteria
frequent
found
lower
airway
copd
patient
stabl
state
exacerb
hostepathogen
relationship
copd
complex
dynam
process
characteris
frequent
chang
pathogen
strain
load
subsequ
host
immun
respons
exacerb
detriment
event
cours
copd
evid
suggest
may
caus
microorgan
consid
bacteri
exacerb
recent
find
base
molecular
type
demonstr
acquisit
new
strain
bacteria
antigen
chang
preexist
strain
import
trigger
exacerb
onset
even
clinic
stabl
copd
patient
presenc
microorgan
lower
airway
may
caus
harm
effect
induc
chronic
lowgrad
airway
inflamm
lead
increas
exacerb
frequenc
acceler
declin
lung
function
impair
healthrel
qualiti
life
besid
intralumin
localis
distal
airway
bacteria
found
bronchial
wall
parenchym
lung
tissu
copd
patient
therefor
isol
pathogen
bacteria
stabl
copd
consid
form
chronic
infect
rather
colonis
new
approach
may
import
implic
manag
patient
copd
elsevi
ltd
right
reserv
role
microorgan
especi
bacteria
pathogenesi
chronic
obstruct
pulmonari
diseas
copd
focu
interest
sever
decad
although
mani
question
remain
answer
microorgan
consid
among
main
aetiolog
factor
copd
role
minimis
interest
subject
rekindl
recent
year
introduct
new
research
techniqu
provid
interest
rather
surpris
discoveri
difficulti
limit
microbiolog
assess
differ
respiratori
sampl
unclear
signific
isol
pathogen
stabl
copd
exacerb
absenc
standardis
definit
copd
exacerb
problem
face
investig
issu
address
depth
review
anoth
topic
discuss
detail
signific
presenc
microorgan
particularli
bacteri
distal
airway
stabl
copd
recent
becom
increas
interest
due
emerg
evid
microorgan
may
activ
role
evolut
diseas
microorgan
one
main
aetiolog
factor
involv
exacerb
copd
contrast
understand
role
stabl
phase
diseas
still
incomplet
although
studi
suggest
activ
contribut
chronic
airway
inflamm
lead
progress
copd
knowledg
bacteri
speci
found
lower
airway
stabl
copd
base
qualit
quantit
cultur
spontan
induc
sputum
sampl
bronchoscop
protect
specimen
brush
psb
well
bronchial
lavag
bl
bronchoalveolar
lavag
bal
sampl
novel
noncultur
detect
method
recent
introduc
respiratori
research
although
broader
use
remain
limit
cost
nonculturebas
techniqu
includ
polymeras
chain
reaction
pcr
detect
microbi
nucleic
acid
respiratori
specimen
molecular
type
base
polyacrylamid
pulsedfield
gel
electrophoresi
distinguish
differ
bacteri
strain
situ
hybridis
immunofluoresc
microscopi
detect
intracellular
microorgan
bronchial
biopsi
specimen
although
sputum
sampl
easier
collect
sampl
mainli
obtain
larg
airway
often
contamin
upper
airway
microbi
flora
therebi
reduc
reliabl
cultur
addit
pcr
studi
detect
bacteri
nucleic
acid
demonstr
fals
neg
sputum
cultur
contrast
contamin
upper
airway
flora
avoid
use
psb
bl
bal
cultur
sampl
use
fiberopt
bronchoscopi
inher
risk
cost
addit
bronchoscop
method
unsuit
repeat
sampl
requir
longitudin
studi
anoth
point
taken
consider
regard
colonis
cutoff
valu
defin
posit
cultur
case
arbitrari
threshold
posit
cultur
use
recent
publish
studi
follow
colonyform
unitsmillilitr
cfuml
sputum
cfuml
bl
cfuml
psb
bal
sampl
bacteri
speci
isol
respiratori
specimen
usual
divid
two
group
potenti
pathogen
microorgan
ppm
nonpotenti
pathogen
microorgan
nonppm
nonppm
usual
involv
respiratori
infect
immunocompet
individu
belong
normal
oropharyng
gastrointestin
flora
includ
bacteria
corynebacterium
spp
neisseria
spp
enterococcu
spp
coagulaseneg
staphylococcu
spp
streptococcu
viridan
group
fungi
candida
spp
distribut
bacteri
speci
ppm
nonppm
may
chang
time
accord
evid
emerg
exampl
catarrhali
previous
known
neisseria
catarrhali
branhamella
catarrhali
first
consid
nonppm
deem
ppm
opposit
situat
might
occur
near
futur
h
haemolyticu
h
parainfluenza
sinc
recent
find
suggest
pathogen
potenti
much
lower
comparison
ppm
author
alreadi
start
categoris
nonppm
pseudomona
spp
predominantli
appear
advanc
diseas
howev
unusu
one
pathogen
simultan
isol
patient
commonli
believ
lower
respiratori
tract
healthi
nonsmok
individu
steril
investig
shown
lower
airway
healthi
subject
also
colonis
although
colonis
rate
rel
low
caus
mainli
nonppm
tabl
except
studi
weinreich
et
al
even
healthi
subject
current
smoke
statu
unknown
posit
cultur
bl
sampl
although
ppm
isol
tabl
rate
posit
cultur
stabl
copd
vari
depend
sampl
techniqu
cutoff
point
employ
studi
use
sputum
sampl
cultur
posit
bacteria
posit
ppm
tabl
psb
sampl
colonis
rate
somewhat
lower
expect
rang
ppm
isol
tabl
similarli
bal
bl
cultur
posit
case
ppm
isol
tabl
studi
investig
distal
airway
colonis
copd
patient
previous
proven
bronchiectasi
exclud
analysi
introduct
highresolut
comput
tomographi
hrct
routin
clinic
practic
becom
clear
bronchiectasi
differ
degre
extent
common
featur
copd
patient
therefor
expect
preval
rate
bronchial
colonis
copd
could
even
higher
suggest
previous
mention
studi
agreement
presumpt
colonis
rate
ppm
two
studi
bronchoscop
sampl
preform
stabl
patient
bronchiectasi
copd
tabl
furthermor
studi
stabl
copd
patel
et
al
exclud
patient
previous
diagnos
clinic
evid
bronchiectasi
studi
popul
fulfil
radiolog
criteria
bronchiectasi
hrct
posit
correl
found
lower
lobe
bronchiectasi
distal
airway
colonis
bronchial
inflamm
recent
studi
martinezgarcia
et
al
preval
subclin
bronchiectasi
stabl
copd
even
higher
significantli
associ
higher
rate
bronchial
colonis
increas
system
inflamm
measur
fibrinogen
plasma
level
sensit
novel
nonculturebas
techniqu
detect
presenc
microorgan
even
greater
recent
demonstr
use
pcr
techniqu
microbi
nucleic
acid
extract
certain
proport
cultur
neg
respiratori
specimen
assum
nucleic
acid
repres
viabl
bacteria
would
indic
even
higher
rate
colonis
cultur
find
suggest
addit
microorgan
abl
invad
surviv
within
airway
epitheli
cell
macrophag
use
situ
hybridis
immunofluoresc
microscopi
detect
intracellular
nthi
bronchial
biopsi
microorgan
found
stabl
sever
exacerb
chronic
bronchiti
patient
respect
healthi
adult
frequent
identifi
risk
factor
colonis
ppm
current
previou
smoke
impair
lung
function
defin
reduct
fev
andor
forc
vital
capac
fvc
comorbid
condit
increas
rate
previou
exacerb
presenc
bronchiectasi
purul
sputum
increas
degre
dyspnoea
also
recognis
clinic
indic
posit
sputum
cultur
ppm
stabl
copd
hostepathogen
interact
complex
crucial
establish
prolifer
microorgan
lower
airway
interact
best
describ
nthi
involv
adher
mucou
membran
extracellular
matrix
damag
epitheli
cell
ciliotox
activ
increas
mucin
product
well
complex
mechan
evad
host
immun
defenc
invas
epitheli
cell
product
iga
proteas
antigen
heterogen
host
factor
reduc
mucociliari
clearanc
mucu
hypersecret
bronchiectasi
also
involv
although
alway
clear
whether
featur
realli
risk
factor
acquir
bacteria
consequ
recent
find
stress
role
innat
immun
impair
copd
among
other
may
manifest
defect
phagocytosi
hyporespons
alveolar
macrophag
bacteri
antigen
lead
reduc
clearanc
bacteri
pathogen
subsequ
predisposit
colonis
infect
copd
characteris
differ
degre
chronic
inflamm
affect
larg
small
airway
well
lung
parenchyma
pulmonari
vasculatur
consid
copd
inflammatori
disord
sever
studi
attempt
clarifi
impact
bacteri
colonis
mediat
inflammatori
process
beyond
effect
cigarett
smoke
bacteria
releas
molecul
potent
proinflammatori
effect
endotoxin
eg
lipooligosaccharid
nthi
outer
membran
lipoprotein
eg
outer
membran
protein
lead
recruit
activ
neutrophil
macrophag
inflammatori
cell
neutrophil
prevail
bronchial
secret
copd
patient
healthi
smoker
recruit
circul
activ
respons
chemoattract
particularli
leukotrien
via
adhes
molecul
eselectin
intercellular
adhes
molecul
icam
express
vascular
endothelium
activ
neutrophil
degranul
releas
myeloperoxidas
differ
type
proteinas
elastas
cathepsin
g
proteinas
matrix
metalloproteinas
togeth
particip
variou
aspect
tissu
damag
colonis
copd
patient
higher
concentr
inflammatori
cytokin
neutrophil
product
respiratori
secret
comparison
noncolonis
patient
similar
degre
airflow
obstruct
would
indic
higher
level
airway
inflamm
induc
bacteria
differ
bacteri
speci
even
differ
strain
speci
differ
virul
inflammatori
potenti
studi
hill
et
al
p
aeruginosa
recognis
potent
induc
inflamm
follow
nthi
wherea
catarrhali
provok
significantli
milder
reaction
addit
sethi
et
al
demonstr
signific
inflammatori
potenti
nthi
catarrhali
h
parainfluenzaeassoci
exacerb
inflammatori
profil
similar
ppmneg
exacerb
furthermor
interspeci
divers
durat
colonis
eg
catarrhali
usual
clear
respiratori
tract
effici
even
without
antibiot
within
period
one
month
carriag
nthi
p
aeruginosa
particularli
mucoid
strain
may
last
much
longer
bacteri
colonis
dynam
process
chang
pathogen
strain
load
occur
time
suggest
chang
bacteri
strain
andor
rise
bacteri
load
increas
degre
airway
system
inflamm
trigger
onset
exacerb
discuss
detail
later
adult
acquir
bacteria
respiratori
tract
develop
immun
respons
demonstr
studi
murphi
et
al
episod
acquisit
catarrhali
follow
system
serum
igg
andor
mucos
sputum
iga
antibodi
respons
homolog
strain
clinic
import
colonis
patient
wors
health
statu
increas
exacerb
frequenc
well
symptom
exacerb
bacteria
may
also
contribut
acceler
declin
lung
function
consequ
progress
copd
support
studi
wilkinson
et
al
declin
fev
relat
chang
colonis
bacteri
type
rise
airway
bacteri
load
observ
confirm
recent
studi
patient
moder
copd
neutrophil
airway
inflamm
mainli
found
patient
colonis
ppm
associ
twofold
increas
risk
fev
declin
median
declin
followup
bacteria
may
acceler
fev
declin
directli
increas
basal
airway
inflamm
stabl
state
well
indirectli
induc
frequent
sever
exacerb
view
clear
isol
ppm
respiratori
sampl
fulfil
definit
colonis
associ
inflammatori
respons
signific
damag
target
organ
recent
suggest
term
chronic
bronchial
infect
would
appropri
address
presenc
signific
concentr
ppm
lower
airway
stabl
copd
patient
chronic
bronchial
infect
copd
defin
presenc
ppm
respiratori
secret
caus
inflammatori
reaction
manifest
chronic
product
colouredpurul
sputum
syndrom
accompani
recurr
infect
exacerb
system
manifest
form
malais
febricula
asthenia
weight
loss
similar
describ
patient
bronchiectasi
fact
patient
signific
bronchiectasi
studi
hrct
scan
studi
et
al
isol
ppm
sputum
patient
stabl
copd
togeth
fev
predict
histori
least
one
hospit
admiss
exacerb
previou
year
associ
probabl
bronchiectasi
ct
scan
convers
term
colonis
use
describ
isol
nonppm
distal
respiratori
tract
either
healthi
subject
patient
chronic
airway
diseas
besid
common
bacteria
respiratori
virus
atyp
bacteria
form
chronic
infect
may
also
impact
cours
copd
seemung
et
al
analys
nasal
aspir
blood
sampl
stabl
copd
patient
pcr
detect
lowgrad
viral
infect
respiratori
syncyti
viru
rsv
patient
well
infect
virus
rsv
dominantli
rhinovirus
coronavirus
patient
patient
viru
detect
like
increas
exacerb
frequenc
well
higher
concentr
serum
plasma
fibrinogen
potenti
predisposit
thrombot
event
stabl
furthermor
examin
lung
tissu
smoker
differ
degre
emphysema
retamal
et
al
determin
increas
number
alveolar
epitheli
cell
express
adenovir
protein
mild
sever
emphysema
respect
suggest
impact
latent
adenovir
infect
amplif
cigarett
smokeinduc
lung
inflamm
present
sever
emphysema
addit
promot
inflammatori
process
lower
respiratori
viral
atyp
bacteri
infect
may
enhanc
suscept
airway
pathogen
one
exampl
chronic
chlamydophila
pneumonia
infect
copd
patient
associ
higher
rate
airway
colonis
common
bacteria
frequent
exacerb
sever
function
impair
exacerb
rel
frequent
event
cours
copd
especi
moderatetosever
diseas
signific
impact
health
statu
qualiti
life
diseas
progress
mortal
healthcar
utilis
cost
discuss
role
microorgan
exacerb
copd
ecopd
mention
still
standardis
definit
ecopd
reason
probabl
lie
complex
pathophysiolog
differ
aetiolog
factor
involv
well
varieti
clinic
manifest
present
patient
american
thorac
societyeuropean
respiratori
societi
atser
task
forc
copd
defin
ecopd
increas
respiratori
symptom
baselin
usual
requir
chang
therapi
nonetheless
wide
use
clinic
criteria
ecopd
increas
dyspnoea
sputum
volum
sputum
purul
defin
anthonisen
et
al
base
probabl
respons
antibiot
therapi
despit
limit
defin
ecopd
investig
preform
recent
year
sought
establish
underli
pathophysiolog
process
event
comparison
stabl
state
acut
increas
level
airway
inflamm
period
exacerb
assess
rise
sputum
inflammatori
cell
neutrophil
eosinophil
lymphocyt
differ
inflammatori
mediat
includ
tnfa
neutrophil
proteas
myeloperoxidas
eosinophil
cation
protein
ecp
rant
regul
upon
activ
normal
tcell
express
secret
intensifi
inflamm
may
induc
airway
mucos
oedema
bronchospasm
mucu
hypersecret
lead
increas
respiratori
symptom
associ
neutrophil
inflamm
sputum
purul
bacteri
exacerb
well
establish
provid
rational
use
sputum
purul
clinic
indic
bacteri
infect
need
antibiot
therapi
addit
sputum
neutrophilia
posit
correl
sever
exacerb
assess
impair
lung
function
level
hypoxia
inflamm
ecopd
limit
lower
airway
also
certain
degre
upper
airway
system
inflamm
proport
lower
airway
inflamm
higher
bacteri
exacerb
furthermor
clinic
sever
exacerb
significantli
correl
level
local
system
inflamm
publish
data
suggest
exacerb
caus
respiratori
infect
includ
aerob
bacteria
respiratori
virus
atyp
bacteria
author
demonstr
polymicrobi
aetiolog
much
exacerb
particularli
import
sever
case
environment
factor
includ
low
temperatur
air
pollut
exposur
higher
level
black
smoke
particul
matter
sulphur
dioxid
nitrogen
dioxid
ozon
consid
caus
approxim
ecopd
depend
season
geograph
set
furthermor
noncompli
therapi
andor
abrupt
withdraw
therapi
provoc
factor
exacerb
nonetheless
certain
proport
ecopd
aetiolog
remain
unknown
consid
bacteri
exacerb
nthi
pneumonia
catarrhali
frequent
isol
ppm
respiratori
secret
exacerb
similar
occur
stabl
state
gramneg
bacteria
p
aeruginosa
stenotrophomona
maltophilia
member
enterobacteriacea
famili
often
present
patient
greater
degre
function
impair
recent
antibiot
system
steroid
therapi
sever
exacerb
interestingli
ppm
isol
frequent
higher
load
exacerb
compar
stabl
state
found
exacerb
patient
use
psb
sampl
tabl
usual
cfuml
sputum
cultur
cfuml
psb
cultur
mention
previous
search
presenc
nthi
intracellularli
bronchial
mucosa
exacerb
chronic
bronchiti
nthi
detect
frequent
comparison
stabl
state
find
fact
sever
bronchial
inflamm
directli
correl
bacteri
load
led
develop
fall
rise
quantit
hypothesi
bacteri
ecopd
base
hypothesi
symptom
exacerb
appear
inflammatori
reaction
caus
increas
bacteri
load
airway
exce
certain
threshold
determin
combin
bacteri
host
factor
hand
recent
find
base
molecular
type
bacteri
isol
suggest
acquisit
new
strain
bacteria
antigen
chang
preexist
strain
crucial
pathogenesi
bacteri
exacerb
chang
bacteri
load
subsequ
enhanc
inflamm
secondari
phenomena
follow
cohort
ambulatori
copd
patient
four
year
sethi
et
al
demonstr
acquisit
new
strain
nthi
pneumonia
catarrhali
associ
twofold
higher
risk
exacerb
recent
studi
similar
design
longer
followup
murphi
et
al
shown
associ
chang
strain
occurr
exacerb
also
exist
p
aeruginosa
suggest
new
strain
acquir
due
absenc
effect
host
immun
respons
bacteria
may
intens
prolifer
airway
result
higher
bacteri
load
sever
local
system
inflamm
develop
symptom
exacerb
immun
respons
infect
strain
develop
ecopd
strainspecif
protect
acquisit
new
strain
may
explain
recurr
exacerb
even
speci
moreov
specif
immun
respons
provid
indirect
evid
particular
microorgan
actual
caus
exacerb
howev
chang
strain
may
mechan
exacerb
previous
mention
studi
respect
visit
involv
isol
new
bacteri
strain
associ
onset
exacerb
addit
studi
certain
proport
exacerb
diagnos
visit
isol
bacteria
belong
new
strain
also
exacerb
occur
visit
without
isol
bacteri
pathogen
seem
increas
airway
inflamm
clinic
manifest
exacerb
result
complex
hostepathogen
interact
chang
bacteri
strain
play
central
role
factor
may
influenc
well
eg
host
defenc
virul
capac
differ
strain
bacteri
speci
presenc
microorgan
bacteria
nonmicrobi
provoc
factor
among
other
role
virus
atyp
bacteria
exacerb
copd
role
virus
atyp
bacteria
ecopd
recent
receiv
increas
attent
thank
novel
diagnost
techniqu
pcr
revers
transcript
pcr
rtpcr
higher
sensit
detect
pathogen
compar
previous
establish
method
cell
cultur
serolog
systemat
review
preval
viral
infect
ecopd
includ
eight
studi
use
pcr
andor
rtpcr
sputum
nasal
lavag
fluid
sampl
weight
mean
preval
respiratori
viral
infect
high
one
studi
picornaviru
especi
rhinoviru
commonli
detect
follow
influenza
preval
depend
vaccin
statu
studi
popul
respiratori
syncyti
viru
coronaviru
parainfluenza
adenoviru
human
metapneumoviru
detect
significantli
smaller
percentag
consid
clinic
present
viral
exacerb
associ
higher
total
symptom
count
present
higher
frequenc
addit
symptom
cold
sore
throat
increas
dyspnoea
fever
slower
recoveri
frequent
previou
exacerb
direct
evid
causal
relationship
viral
infect
ecopd
recent
obtain
studi
mallia
et
al
demonstr
experiment
rhinoviru
infect
subject
copd
induc
clinic
inflammatori
chang
similar
seen
natur
occur
exacerb
infect
rhinoviru
copd
patient
develop
sever
prolong
respiratori
symptom
greater
lung
function
impair
increas
airway
inflamm
comparison
healthi
control
author
suggest
experiment
rhinoviru
infect
may
use
futur
human
model
ecopd
atyp
bacteria
c
pneumonia
mycoplasma
pneumonia
legionella
spp
intracellular
pathogen
share
characterist
virus
contribut
emerg
exacerb
complet
clear
data
preval
significantli
differ
depend
diagnost
method
studi
popul
involv
commonli
accept
atyp
bacteria
caus
ecopd
either
independ
pathogen
frequent
copathogen
howev
sever
serolog
studi
much
higher
proport
exacerb
patient
evid
recent
infect
c
pneumonia
pneumonia
legionella
spp
e
respect
polymicrobi
aetiolog
frequent
found
sever
ecopd
manifest
either
simultan
coinfect
secondari
bacteri
viral
infect
vice
versa
one
propos
mechan
interact
virus
bacteria
includ
chang
receptor
molecul
respiratori
epitheli
cell
induc
one
microorgan
lead
increas
suscept
microorgan
evid
patient
polymicrobi
exacerb
sever
deterior
lung
function
higher
symptom
count
longer
hospitalis
copd
chronic
infect
diseas
although
smoke
cessat
effect
slow
acceler
declin
lung
function
observ
inflammatori
process
lung
patient
copd
continu
smoke
cessat
aspect
may
even
increas
contrari
case
healthi
exsmok
whose
airway
inflamm
usual
decreas
furthermor
inflamm
copd
patient
limit
lung
name
persist
system
inflamm
well
suggest
promot
ongo
inflamm
exsmok
copd
patient
microorgan
autoimmun
inflamm
part
repair
process
recoveri
proinflammatori
capac
epitheli
cell
smoke
cessat
disappear
antiinflammatori
factor
carbon
monoxid
cigarett
smoke
howev
review
evid
microorgan
emerg
like
candid
perpetu
bronchial
inflamm
favour
hypothesi
moller
et
al
detect
h
influenza
frequent
tissu
section
lung
patient
copd
cystic
fibrosi
other
analys
lung
explant
transplant
recipi
differ
endstag
pulmonari
diseas
result
indic
generalis
distribut
h
influenza
lung
patient
presenc
bacteria
epithelium
submucosa
bronchi
bronchiol
parenchym
lung
tissu
alveolar
epithelium
interstitium
alveoli
well
viscer
pleura
vitro
vivo
studi
confirm
abil
bacteria
invad
lung
tissu
persist
therein
apart
frequent
intralumin
localis
bacteria
airway
copd
patient
suggest
tissu
reservoir
protect
patient
circul
antibiot
effect
host
immun
defenc
may
serv
endogen
sourc
recurr
infect
well
chronic
inflammatori
stimulu
hypothesi
chronic
microbi
stimul
support
histolog
chang
observ
lung
copd
patient
name
besid
tissu
remodel
progress
diseas
lead
increas
infiltr
small
airway
lymphocyt
organis
lymphoid
follicl
probabl
adapt
immun
respons
persist
microbi
stimul
evid
suggest
togeth
smoke
microorgan
play
signific
role
develop
progress
copd
sequenc
event
pathogenesi
copd
microbi
involv
summaris
fig
import
differ
chronic
infect
diseas
copd
involv
one
caus
pathogen
rather
chang
pathogen
strain
load
occur
time
whether
influenc
infect
exist
copd
patient
infect
phenotyp
still
need
establish
sinc
previou
longitudin
studi
investig
issu
includ
copd
patient
chronic
bronchiti
fact
even
exacerb
may
differ
phenotyp
bacteri
exacerb
present
particular
inflammatori
profil
differ
viral
socal
eosinophilicpredomin
pauciinflammatori
interestingli
bacteri
exacerb
phenotyp
identifi
stabl
state
patient
infect
phenotyp
patient
develop
type
phenotyp
bacteri
exacerb
success
episod
infect
phenotyp
copd
could
describ
patient
chronic
product
colour
sputum
stabl
state
recurr
bacteri
exacerb
frequent
associ
bronchiectasi
word
infect
phenotyp
copd
refer
patient
syndrom
chronic
bronchial
infect
howev
mani
aspect
relationship
infect
acut
chronic
copd
requir
research
eg
signific
simultan
isol
multipl
bacteri
strain
possibl
cooper
ppm
nonppm
diseas
progress
develop
antibiot
resist
mechan
interact
differ
pathogen
polymicrobi
infect
well
relat
microbi
environment
factor
pathogenesi
exacerb
use
novel
molecular
cellular
immunolog
techniqu
crucial
progress
research
addit
effort
made
seek
new
reliabl
noninvas
method
detect
lower
airway
infectioninflamm
order
avoid
limit
sputum
cultur
inconveni
bronchoscop
sampl
evid
impact
bacteria
copd
expect
result
current
ongo
clinic
trial
antibiot
stabl
copd
final
relev
describ
microbiota
lung
health
must
establish
molecular
cultureindepend
techniqu
identifi
bacteria
previous
amen
cultur
analysi
highli
conserv
rrna
gene
use
assign
phylogeni
allow
pictur
complet
microbi
commun
environ
bronchial
tree
construct
offer
comprehens
analysi
classic
culturebas
techniqu
number
studi
examin
lower
airway
microbiom
limit
overlap
bacteria
seen
copd
healthi
individu
howev
recent
studi
report
significantli
differ
bacteri
commun
microbiom
patient
sever
copd
compar
nonsmok
smoker
patient
cystic
fibrosi
studi
clearli
need
understand
role
microbiom
healthi
individu
patient
copd
figur
impact
microbi
infect
pathogenesi
copd
stabl
state
exacerb
sinc
current
evid
role
atyp
bacteria
incomplet
present
dash
line
copd
chronic
obstruct
pulmonari
diseas
ppm
potenti
pathogen
microorgan
sharp
dohm
nycom
grant
support
talecri
zinka
matkov
conflict
interest
disclos
